Tag: Bayer

July 10, 2023

Not intended for U.S. and UK Media Study plans to investigate elinzanetant as non-hormonal treatment for vasomotor symptoms caused by ...

Health

“Bayer has excellent prospects for the future”

July 9, 2023

Leverkusen, April 28, 2023 – Bayer strengthened its position as a successful life science company in 2022 despite the difficult ...

Health

Bayer to distribute pheromone-based biological crop protection solutions from M2i Group

July 9, 2023

31 January 2023 | 08:59 AM Europe/Amsterdam 2023-0021 Pheromone-based crop protection products help farmers control pests in an environmentally friendly ...

Health

Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros

July 9, 2023

Not intended for U.S. and U.K. Media Berlin, January 10, 2023 – On the occasion of the 41st J.P. Morgan ...

Health

Bayer to invest a total of 60 million euros in its Ukrainian seed production site

Leverkusen/Kyiv, April 5, 2023 – Bayer has revealed an investment of overall 60 million euros from 2023 onwards in its ...

Health

Bayer establishes Bioethics Council

Leverkusen, April 3, 2023 – Bayer AG has established a Bioethics Council consisting of internationally renowned experts, to provide broad ...

Health

Bayer pledges to help tackle global water crisis with new water strategy

Leverkusen, March 21, 2023 – Bayer is launching its new water strategy at the UN 2023 Water Conference in New ...

Health

Bayer submits aflibercept 8 mg for marketing authorization in Japan

01 March 2023 | 07:59 AM Europe/Amsterdam Not intended for U.S. and UK Media Summary Submission to the Ministry of ...

Health

Bayer to start Phase III study with finerenone in adults with chronic kidney disease and type 1 diabetes

July 5, 2023